Related Experiment Video
Updated: Dec 12, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Pathological Consequences of Hepatic mTORC1 Dysregulation
Chun-Seok Cho1, Allison Ho Kowalsky1,2, Jun Hee Lee1
1Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
Mammalian target of rapamycin complex 1 (mTORC1) regulates metabolism and cell growth. Proper liver mTORC1 regulation is crucial for preventing liver injury and disease, aiding in functional restoration.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Regulation
Background:
- The mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cellular metabolism.
- It integrates signals from nutrients, growth factors, and stress to control anabolic and catabolic processes.
- Dysregulation of mTORC1 is implicated in numerous diseases, including cancer and metabolic syndromes.
Purpose of the Study:
- To highlight the critical role of mTORC1 in liver homeostasis.
- To discuss the consequences of mTORC1 dysregulation in liver pathologies.
- To emphasize the therapeutic potential of regulating mTORC1 in liver diseases.
Main Methods:
- Literature review on mTORC1 signaling pathways.
- Analysis of mTORC1's role in cellular anabolism and catabolism.
- Examination of mTORC1's involvement in liver disease pathogenesis.
Main Results:
- mTORC1 activation promotes macromolecule synthesis (proteins, lipids, nucleic acids) and inhibits autophagy.
- Aberrant mTORC1 activity in the liver leads to hepatocellular damage and carcinogenesis.
- Controlled mTORC1 signaling is essential for maintaining liver function.
Conclusions:
- Proper mTORC1 regulation is vital for liver health and preventing disease.
- Targeting mTORC1 may offer therapeutic strategies for liver conditions.
- Restoring mTORC1 balance can ameliorate liver failure consequences.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation